Top 5 Pharmacy Times Health Systems Articles of 2023

1. FDA Issues Fast Track Designation to ADP101 for Mono-, Multi-Food Allergies

The designation allows expedited development of ADP101 as a treatment for food allergy in children ages 4 to 17 with confirmed allergy to 1 or more of the 15 foods in the drug product. Read More Here.

bixpicture - stock.adobe.com

2. Patient-Reported Questionnaire Could Aid the Evaluation of Respiratory Syncytial Virus Symptoms

Findings suggest that psychometric tests used for The Respiratory Infection Intensity and Impact Questionnaire provide reliable, constructive validity and responsive evidence to detect onset symptoms of RSV. Read More Here.

3. Treatment of Acute, Uncomplicated Urinary Tract Infections with Ampicillin for Vancomycin-Resistant Enterococcus Species

The incidence of vancomycin-resistant enterococci has nearly doubled in recent years. Read More Here.

4. Survey: 72% of Pharmacy Technicians’ Workflow Affected by Drug Shortages

Chemotherapy, medication for attention deficit/hyperactivity disorder, glucagon-like peptide-1 agonists for weight loss and diabetes, and local anesthetics were among the drugs most affected by shortages in 2023. Read More Here.

5. Sandoz Launches Citrate-Free Adalimumab-Adaz as Biosimilar for Humira

Adalimumab-adaz HCF in the 100 mg/mL strength is approved for indications that are no longer covered exclusively for the reference Humira after July 2023. Read More Here.